Cynthia J. Hommerding

Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity

Katharina Hopp, Christopher J. Ward, Cynthia J. Hommerding et al. · Journal of Clinical Investigation · 2012 · 451 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner

Vladimir G. Gainullin, Katharina Hopp, Christopher J. Ward et al. · Journal of Clinical Investigation · 2015 · 135 citations · Full text

Medicine, Genetics, Nephrology +15

Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3

Rachaneekorn Tammachote, Cynthia J. Hommerding, Rachel M. Sinders et al. · Human Molecular Genetics · 2009 · 123 citations · Full text

Life Sciences, Genetics, Pathology +8

Tolvaptan plus Pasireotide Shows Enhanced Efficacy in a PKD1 Model

Katharina Hopp, Cynthia J. Hommerding, Xiaofang Wang et al. · Journal of the American Society of Nephrology · 2014 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis

Katharina Hopp, Christina M. Heyer, Cynthia J. Hommerding et al. · Human Molecular Genetics · 2011 · 88 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17